Meta-analysis underscores the need for improved HCC surveillance in NAFLD without cirrhosisMarch 21, 2022Hepatocellular Carcinoma
LEN-TACE sequential therapy tops LEN monotherapy in unresectable HCC responsive to initial LEN treatmentMarch 21, 2022Hepatocellular Carcinoma
Final phase 2 results testify to the clinical advantage of TACE plus sorafenib in unresectable HCCMarch 21, 2022Hepatocellular Carcinoma
Overall survival after curative resection for HBV-related HCC is better with tenofovir vs. entecavirMarch 21, 2022Hepatocellular Carcinoma
Clinical Presentation of Subacute Combined Degeneration in a Patient With Chronic B12 DeficiencyMarch 21, 2022Neurology
U.S. primary care seen lagging in key markersMarch 18, 2022Business of MedicineMixed TopicsDiversity in Medicine
